Clinical Trial Update: Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating total neoadjuvant therapy with modified FOLFOX (5-fluorouracil, leucovorin, oxaliplatin) and short-course radiation for rese…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Rectal Cancer | Phase 2 | Status: RECRUITING